<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02747680</url>
  </required_header>
  <id_info>
    <org_study_id>8597</org_study_id>
    <nct_id>NCT02747680</nct_id>
  </id_info>
  <brief_title>Cerebral Responses to Insulin Induced Hypoglycemia</brief_title>
  <acronym>1018</acronym>
  <official_title>Cerebral Responses to Insulin Induced Hypoglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is designed to investigate the effect of hypoglycemia (low blood sugar)&#xD;
      on blood flow to and biochemistry in the brain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to better understand the effect of low blood sugar&#xD;
      (hypoglycemia) on blood flow and biochemistry in the brain. Hypoglycemia is a serious&#xD;
      complication of diabetes treatments. It has been previously observed that hypoglycemia causes&#xD;
      an increase in blood flow to certain parts of the brain, but it has been difficult to&#xD;
      determine which parts of the brain specifically have an increase in blood flow. With new&#xD;
      technology, it is now possible to determine the rate of blood flow in very small parts of the&#xD;
      brain. The investigator expects that people with type 1 diabetes and hypoglycemia&#xD;
      unawareness, poorly controlled diabetes, and normal subjects will have different rates of&#xD;
      blood flow to different parts of the brain in response to hypoglycemia. Having a greater&#xD;
      understanding of how the brain adapts to hypoglycemia may help us develop better ways to&#xD;
      treat diabetes more safely.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2004</start_date>
  <completion_date type="Actual">December 2020</completion_date>
  <primary_completion_date type="Actual">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activation during euglycemia (normal blood sugar) using functional MRI</measure>
    <time_frame>baseline</time_frame>
    <description>Brain activation during euglycemia (normal blood sugar) using functional MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Brain activation during hypoglycemia (low blood sugar) using functional MRI</measure>
    <time_frame>baseline</time_frame>
    <description>Brain activation during hypoglycemia (low blood sugar) using functional MRI</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">266</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Healthy</condition>
  <condition>Hypoglycemia Unawareness</condition>
  <arm_group>
    <arm_group_label>type 1 diabetes</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>type 1 diabetes &gt;5 years duration Well controlled (a1c &lt;7.5%)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>healthy controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hypoglycemia (low blood sugar) in MRI</intervention_name>
    <description>hypoglycemia (low blood sugar) in MRI</description>
    <arm_group_label>healthy controls</arm_group_label>
    <arm_group_label>type 1 diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  well controlled type 1 diabetes (hemoglobin A1C &lt;7.5%)&#xD;
&#xD;
          -  healthy controls&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of stroke, seizures, neurosurgical procedures, or arrhythmias&#xD;
&#xD;
          -  Use of drugs that can alter GABA (gamma-aminobutyric acid) metabolism (such as&#xD;
             benzodiazepines).&#xD;
&#xD;
          -  Subjects must also meet requirements for a study in the magnet, which includes weight&#xD;
             less than 300 lbs and the absence of metallic substances in their body.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth Seaquist, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>April 11, 2016</study_first_submitted>
  <study_first_submitted_qc>April 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2016</study_first_posted>
  <last_update_submitted>January 29, 2021</last_update_submitted>
  <last_update_submitted_qc>January 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>type 1 diabetes</keyword>
  <keyword>hypoglycemia unawareness</keyword>
  <keyword>healthy control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Unconsciousness</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

